HOME >> BIOLOGY >> NEWS
2007 Joint Assembly in Acapulco -- press conference schedule

ities greater than 10 million inhabitants) are multiplying, particularly in South America, Asia, and other parts of the developing world. By pumping pollutants into the atmosphere, these hubs of industrial activity and intensive motor-vehicle use cause local, regional, and global effects that are coming into focus as a result of targeted scientific investigations. In this press conference, panelists will discuss some key results from major field studies conducted in Mexico City and So Paulo, Brazil. Among the highlights, scientists find that the chemistry of emissions from developing megacities differs from what's brewing over established megacities, particularly with regard to aerosols important to climate change and health.

Participants

  • Luisa T. Molina: Principal Research Scientist, Department of Earth Atmospheric and Planetary Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; Director, Molina Center for Energy and the Environment (MCE2) Lead scientist, MCMA-2006 /MILAGRO;
  • Jeffrey S. Gaffney: Chair and Professor, Department of Chemistry University of Arkansas, Little Rock, Arkansas, USA; Lead Scientist, MAX-Mex/MILAGRO;
  • Paulo Artaxo: Institute of Physics, University of So Paulo, Rua do Mato, Travessa R, 187 So Paulo, SP, Brazil; Member, Global Air Pollution Forum.

Session: A23C


Tuesday, 22 May
1400h

Keeping Track of Earth's Slippers

One of the great geophysical advances in the last decade has been the development of Global Positioning System (GPS) receivers as tools for directly measuring plate tectonics. Using networks of GPS receivers that routinely gauge deformation in plate boundary zones around the world, scientists find that plates don't just creep along at a steady pace. Rather, they sometimes suddenly speed up or even change directionactions known as slow slip events (SSE) or transient deformation. Nowhere are SSEs more dramat
'"/>

Contact: Peter Weiss
pweiss@agu.org
202-777-7507
American Geophysical Union
18-May-2007


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. National Ecological Observatory Network featured at ESA/SER Joint International Conference
2. DOE Joint Genome Institute secures long-term lease on production genomics facility
3. Joint research on poverty-related diseases
4. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
5. No pain, DOE Joint Genome Institute gains coveted ergonomics prize with Shake N Plate
6. Burnham Institute for Medical Research & UC San Diego establish Joint Center for Molecular Modeling
7. Joint European strategy for industrial biotechnology
8. Report highlights DOE Joint Genome Institute achievements
9. DOE Joint Genome Institute issues new call for large-scale sequencing proposals
10. Joint green chemistry meeting in Washington, D.C., features top experts on environment
11. News tips: NASA presentations at Annual 2005 Joint Assembly Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Joint Assembly Acapulco press conference schedule

(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: